Valeurs | |||||
Le rangement donne un aperçu de toutes les valeurs mobilières classées de manière alphabétique ou selon les indices. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Nom | Code | Analysis date | Cours de clôture | +/- % |
OssDsign | OSSD | 10. jui 2024 | 9.98 | -1.58 |
Peptonic Medical | PMED | 10. jui 2024 | 0.01 | 0.00 |
PharmaLundensis | PHAL | 10. jui 2024 | 0.64 | -0.31 |
Pila Pharma | PILA | 10. jui 2024 | 4.95 | +20.73 |
Polymer Factory Sweden | POLYMER | 10. jui 2024 | 0.79 | 0.00 |
Probi | PROB | 10. jui 2024 | 213.00 | -1.84 |
Promimic AB | PRO | 10. jui 2024 | 35.90 | +6.53 |
QuiaPEG Pharmaceuticals Holding AB | QUIA | 10. jui 2024 | 0.07 | -3.01 |
RaySearch Laboratories B | RAYB | 10. jui 2024 | 148.00 | +0.41 |
Redwood Pharma | REDW | 10. jui 2024 | 0.68 | -8.36 |
Respiratorius | RESP | 10. jui 2024 | 0.07 | -0.83 |
Saniona | SANION | 10. jui 2024 | 3.25 | +6.20 |
Scandinavian ChemoTech B | CMOTECB | 10. jui 2024 | 2.00 | +11.73 |
Scandion Oncology | SCOL | 10. jui 2024 | 0.42 | -13.52 |
Spago Nanomedical | SPAGO | 10. jui 2024 | 0.35 | +13.07 |
Sprint Bioscience | SPRINT | 10. jui 2024 | 1.40 | +7.69 |
Stayble Therapeutics | STABL | 10. jui 2024 | 0.26 | -0.75 |
Stenocare | STENO | 10. jui 2024 | 4.06 | -4.69 |
Swedish Orphan Biovitrum | SOBI | 10. jui 2024 | 273.20 | -2.78 |
SynAct Pharma AB | SYNACT | 10. jui 2024 | 7.00 | +0.14 |
Toleranzia | TOL | 10. jui 2024 | 0.69 | -1.43 |
Vicore Pharma Holding | VICO | 10. jui 2024 | 22.70 | -1.73 |
Vitrolife | VITR | 10. jui 2024 | 178.70 | -1.33 |
Vivesto | VIVE | 10. jui 2024 | 0.31 | 0.00 |
WntResearch | WNT | 10. jui 2024 | 10.75 | +4.37 |
Xbrane Biopharma | XBRANE | 10. jui 2024 | 0.31 | -4.19 |
Xintela | XINT | 10. jui 2024 | 0.26 | +2.38 |
XP Chemistries | XPC | 10. jui 2024 | 0.10 | -9.01 |
Xspray Pharma | XSPRAY | 10. jui 2024 | 75.00 | +4.46 |
Ziccum AB | ZICC | 10. jui 2024 | 5.00 | -3.85 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.